Clarence Patrick Machado Insider Trading $ADVM Adverum Biotechnologies, Inc.
Get free email notifications about insider trading for Clarence Patrick Machado.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Clarence Patrick Machado. Clarence Patrick Machado is Director in MEDIVATION, INC. ($MDVN) and Sr. Vice President and CFO in MEDIVATION, INC. ($MDVN) and Director in CHIMERIX INC ($CMRX) and Director in SCYNEXIS INC ($SCYX) and Director in ENDOCYTE INC ($ECYT) and Director in INOTEK PHARMACEUTICALS CORP ($ITEK) and 10% Owner in Arbutus Biopharma Corp ($TKMR) and Director in Principia Biopharma Inc. ($PRNB) and Director in Adverum Biotechnologies, Inc. ($ADVM) and Director in Turning Point Therapeutics, Inc. ($TPTX) and 10% Owner in Axovant Sciences Ltd. ($AXON) and Director in Axovant Sciences Ltd. ($AXON) and 10% Owner in Myovant Sciences Ltd. ($MYOV) and Director in Arcus Biosciences, Inc. ($RCUS) and 10% Owner in Urovant Sciences Ltd. ($UROV).
Clarence Patrick Machado in Adverum Biotechnologies, Inc.
Trading Symbol: ADVMIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Clarence Patrick Machado: Director
Holdings: 88,182 shares
Latest Transaction: May 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Clarence Patrick Machado in Adverum Biotechnologies, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, TKMR, RCUS, CMRX, ECYT, MDVN, MYOV, PRNB, RCKT, SCYX, AXON, TPTX, UROV
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 14 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 3.70 | 12,500 | 46,250 | 12,500 | |
May 14 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
Mar 24 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Buy | P | 9.92 | 10,000 | 99,196 | 88,182 | 78.2 K to 88.2 K (+12.79 %) |
Jan 19 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Buy | P | 11.52 | 10,000 | 115,174 | 78,182 | 68.2 K to 78.2 K (+14.67 %) |
Jun 25 2020 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
Jan 03 2020 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 11.52 | 15,000 | 172,800 | 15,000 | |
Jan 03 2020 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 11.52 | 15,000 | 172,800 | 15,000 | |
Aug 02 2019 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 13.41 | 45,000 | 603,450 | 45,000 | |
Jun 15 2018 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 6.25 | 35,000 | 218,750 | 35,000 | |
Feb 20 2018 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 6.40 | 10,000 | 64,000 | 10,000 | |
Jun 14 2017 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 2.75 | 33,602 | 92,406 | 33,602 | |
Jun 14 2017 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Grant | A | 0.00 | 22,727 | 0 | 68,182 | 45.5 K to 68.2 K (+50.00 %) |
Mar 16 2017 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 2.75 | 64,767 | 178,109 | 64,767 | |
Mar 16 2017 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Grant | A | 0.00 | 45,455 | 0 | 45,455 | 0 to 45.5 K |
Page: 1